Literature DB >> 14656133

Enzymatic synthesis of 3'-hydroxyacetaminophen catalyzed by tyrosinase.

Edelmira Valero1, M Isabel Lozano, Ramón Varón, Francisco García-Carmona.   

Abstract

3'-Hydroxyacetaminophen, a catechol metabolite of N-acetyl-p-aminophenol (acetaminophen) and N-acetyl-m-aminophenol (a structural analogue of acetaminophen and considered as a possible alternative because it is not hepatotoxic), is enzymatically synthesized for the first time using mushroom tyrosinase. Although reported to be weakly hepatotoxic in vivo, this catechol derivative of acetaminophen is not commercially available. This compound was obtained from its monophenolic precursor, acetaminophen, using the enzyme tyrosinase in the presence of an excess of ascorbic acid, thus reducing back the o-quinone product of catalytic activity to the catechol acetaminophen derivative. A mathematical model of the system is proposed, which is also applicable to the tyrosinase-mediated synthesis of any o-diphenolic compound from its corresponding monophenol. This synthesis procedure is continuous, easy to perform and control, and adaptable to a bioreactor with the immobilized enzyme for industrial purposes in a nonpolluting way.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656133     DOI: 10.1021/bp034075t

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  3 in total

1.  Characterization of the monophenolase activity of tyrosinase on betaxanthins: the tyramine-betaxanthin/dopamine-betaxanthin pair.

Authors:  Fernando Gandía-Herrero; Josefa Escribano; Francisco García-Carmona
Journal:  Planta       Date:  2005-06-21       Impact factor: 4.116

2.  Betaxanthins as substrates for tyrosinase. An approach to the role of tyrosinase in the biosynthetic pathway of betalains.

Authors:  Fernando Gandía-Herrero; Josefa Escribano; Francisco García-Carmona
Journal:  Plant Physiol       Date:  2005-04-01       Impact factor: 8.340

3.  Bananas decrease acetaminophen potency in in vitro assays.

Authors:  Yoshihiro Uesawa; Naotaka Tsuji
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.